Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
Coopting Germline BRCA2 Mutation With an Available PARP Inhibitor to Manage Resistance to EGFR Targeted Therapy in EGFR-Mutated Lung Cancer: Combination of Olaparib With Osimertinib.
Journal: Clinical lung cancer
Published: January 20, 2026
Lung cancer with EGFR PACC mutations: a practical review of available treatment options and novel therapies on the horizon.
Journal: Translational lung cancer research
Published: January 14, 2026
Improving Prostate MRI: Lessons Learned from the American College of Radiology's Prostate MR Image Quality Improvement Collaborative.
Journal: Radiographics : a review publication of the Radiological Society of North America, Inc
Published: December 04, 2025
A Comprehensive Mutational and Histopathological Analysis of STK11-Mutant Non-Small Cell Lung Carcinomas.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: July 17, 2025
Patterns of HER2 expression and genomic correlates in lung cancer, with a focus on preanalytical variables impacting immunohistochemical staining results.
Journal: Journal of clinical pathology
Published: February 03, 2025
Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 13, 2025
How to select between osimertinib or afatinib in P-loop and αC-helix compressing (G719X, S768I) or classical-like (L861Q) EGFR mutations: what preclinical models and clinical data have taught us in the early 2020s.
Journal: Translational cancer research
Published: September 16, 2024
Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 08, 2024
Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusions.
Journal: Cancer cytopathology
Published: May 20, 2024
Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 08, 2024
Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer.
Journal: Cell death & disease
Published: March 27, 2024
Last Updated: 09/26/2026